INDVR Brands Inc. Stock Canadian Securities Exchange
Equities
IDVR
CA45674D1015
Pharmaceuticals
Sales 2020 | 0.84 1.15 | Sales 2021 | 0.9 1.23 | Capitalization | 10.21M 13.95M |
---|---|---|---|---|---|
Net income 2020 | -19M -25.97M | Net income 2021 | -5M -6.83M | EV / Sales 2020 | 252,600,918 x |
Net Debt 2020 | 2.44M 3.34M | Net Debt 2021 | 3.21M 4.38M | EV / Sales 2021 | 14,895,338 x |
P/E ratio 2020 |
-9.78
x | P/E ratio 2021 |
-1.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 45.12% |
1st Jan change | Capi. | |
---|---|---|
+23.05% | 3.5B | |
+109.78% | 1.92B | |
+87.30% | 61.64M |